Status:
COMPLETED
Insulin Resistance, Sarcopenia and Plasma BAIBA Levels
Lead Sponsor:
Tungs' Taichung Metroharbour Hospital
Conditions:
Sarcopenia
Insulin Resistance
Eligibility:
All Genders
20-90 years
Brief Summary
Insulin resistance (IR) is an early metabolic alteration in chronic kidney disease (CKD) patients, becoming almost universal in those who reach the end stage of kidney failure. The skeletal muscle rep...
Detailed Description
Study Design and Population Patients and Methods This study is an observational, cross-sectional and prospective cohort study. One hundred and fifty patients on non-diabetic hemodialysed patients wi...
Eligibility Criteria
Inclusion
- Received stable hemodialysis at least 3 months
Exclusion
- cancer
- heart failure
- severe liver disease
- chronic infection such diabetic foot
Key Trial Info
Start Date :
March 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04309201
Start Date
March 10 2020
End Date
December 31 2020
Last Update
February 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tungs' Taichung MetroHarbour Hospital
Taichung, Taiwan